AR037493A1 - Proceso para la preparacion de hidrobromuro de citalopram - Google Patents
Proceso para la preparacion de hidrobromuro de citalopramInfo
- Publication number
- AR037493A1 AR037493A1 ARP020102723A ARP020102723A AR037493A1 AR 037493 A1 AR037493 A1 AR 037493A1 AR P020102723 A ARP020102723 A AR P020102723A AR P020102723 A ARP020102723 A AR P020102723A AR 037493 A1 AR037493 A1 AR 037493A1
- Authority
- AR
- Argentina
- Prior art keywords
- citalopram
- preparation
- hydrobromide
- citalopram hydrobromide
- formula
- Prior art date
Links
- WIHMBLDNRMIGDW-UHFFFAOYSA-N 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3h-2-benzofuran-5-carbonitrile;hydron;bromide Chemical compound [Br-].O1CC2=CC(C#N)=CC=C2C1(CCC[NH+](C)C)C1=CC=C(F)C=C1 WIHMBLDNRMIGDW-UHFFFAOYSA-N 0.000 title abstract 3
- 229960000584 citalopram hydrobromide Drugs 0.000 title abstract 3
- WSEQXVZVJXJVFP-HXUWFJFHSA-N (R)-citalopram Chemical compound C1([C@@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-HXUWFJFHSA-N 0.000 abstract 3
- 229960001653 citalopram Drugs 0.000 abstract 3
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 abstract 1
- 239000012024 dehydrating agents Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN779DE2001 IN192057B (cg-RX-API-DMAC10.html) | 2001-07-19 | 2001-07-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR037493A1 true AR037493A1 (es) | 2004-11-17 |
Family
ID=11097086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020102723A AR037493A1 (es) | 2001-07-19 | 2002-07-19 | Proceso para la preparacion de hidrobromuro de citalopram |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20040254385A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1412340A4 (cg-RX-API-DMAC10.html) |
| AR (1) | AR037493A1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU2002317420A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2454335A1 (cg-RX-API-DMAC10.html) |
| IN (1) | IN192057B (cg-RX-API-DMAC10.html) |
| WO (1) | WO2003007872A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7884136B2 (en) | 2005-06-27 | 2011-02-08 | Biovail Laboratories International S.R.L. | Modified-release formulations of a bupropion salt |
| BRPI0814556A2 (pt) * | 2007-07-10 | 2015-01-06 | Thomson Licensing | Método para determinar automaticamente um grupo de pares localizados próximo a outro par em uma rede de comunicação e servidor associado, dispositivo de análise e dispositivo de comunicação |
| PE20091156A1 (es) * | 2007-12-17 | 2009-09-03 | Astrazeneca Ab | Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo |
| US8871955B2 (en) | 2010-07-23 | 2014-10-28 | H. Lundbeck A/S | Process for the purification of pharmaceutically acceptable salts |
| CN103936702A (zh) * | 2014-05-07 | 2014-07-23 | 成都诺维尔生物医药有限公司 | 艾司西酞普兰杂质j的合成方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1526331A (en) * | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
| SK283309B6 (sk) * | 1997-07-08 | 2003-05-02 | H. Lundbeck A/S | Spôsob výroby citalopramu a medziprodukty |
| AR032455A1 (es) * | 2000-05-12 | 2003-11-12 | Lundbeck & Co As H | Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva |
-
2001
- 2001-07-19 IN IN779DE2001 patent/IN192057B/en unknown
-
2002
- 2002-07-11 EP EP02745709A patent/EP1412340A4/en not_active Withdrawn
- 2002-07-11 WO PCT/IB2002/002728 patent/WO2003007872A2/en not_active Ceased
- 2002-07-11 AU AU2002317420A patent/AU2002317420A1/en not_active Abandoned
- 2002-07-11 CA CA002454335A patent/CA2454335A1/en not_active Abandoned
- 2002-07-19 AR ARP020102723A patent/AR037493A1/es not_active Application Discontinuation
-
2004
- 2004-05-18 US US10/484,296 patent/US20040254385A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1412340A4 (en) | 2004-12-01 |
| WO2003007872A2 (en) | 2003-01-30 |
| AU2002317420A1 (en) | 2003-03-03 |
| IN192057B (cg-RX-API-DMAC10.html) | 2004-02-14 |
| WO2003007872A3 (en) | 2003-10-23 |
| US20040254385A1 (en) | 2004-12-16 |
| EP1412340A2 (en) | 2004-04-28 |
| CA2454335A1 (en) | 2003-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR100291A2 (es) | Composición catártica | |
| GT200000190A (es) | Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas-4-carboxiamino-2-sustituidas. | |
| MY126559A (en) | Fungicidal 2-methoxybenzophenones | |
| CY1109989T1 (el) | 3,4-di-υποκαθισταμενες cyclobutene-1,2-diones ως συνδετες του υποδοχεα των cxc-χημειοκινων | |
| ES2149734T1 (es) | Metodo para la preparacion de citalopram. | |
| CL2008002673A1 (es) | Procedimiento se preparacion de citalopram que comprende hacer reaccionar un compuesto derivado de benzofurano con un agente eshidratante y una sulfonamida (div. sol. 2003-01). | |
| BR0112812A (pt) | Titanato de potássio e magnésio lepidocrocìtico, método para fabricar o mesmo e material de fricção | |
| DK1485359T3 (da) | Natriumkanalblokkere | |
| EA200400815A1 (ru) | Контролируемый синтез зипразидона и его композиции | |
| ES2159919T3 (es) | Procedimiento para la preparacion de compuestos de tipo ceramidas. | |
| IL151594A0 (en) | Fungicide composition | |
| HRP20080057T3 (en) | 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof | |
| EA199800792A1 (ru) | Способы получения промежуточных соединений для пестицидов | |
| PL350917A1 (en) | C16 unsaturated fp-selective prostaglandins analogs | |
| SE9904044D0 (sv) | Compounds | |
| AR037493A1 (es) | Proceso para la preparacion de hidrobromuro de citalopram | |
| AR087007A2 (es) | Proceso para preparar un derivado tiazolico intermediario en la sintesis de pesticidas de guanidina | |
| EA200200939A1 (ru) | Способ получения циталопрама | |
| AR050709A1 (es) | Metodo para preparar irbesartan e intermediarios del mismo | |
| WO2002096546A8 (de) | Tensidgemisch | |
| PL1831239T3 (pl) | Sposób wytwarzania gamma-laktonu kwasu 17-hydroksy-6 beta, 7 beta,15 beta, 16 beta-bismetyleno-17 alpha-pregn-4-en-3-ono-21-karboksylowego i związki pośrednie kluczowe dla tego sposobu | |
| SE9904045D0 (sv) | Compounds | |
| EA200100853A1 (ru) | Резорциновая композиция | |
| BG107048A (en) | Method for the preparation of citalopram | |
| BR9909029A (pt) | Estabilização de poliisocianatos orgânicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |